About D2L Clinical Solutions
D2L Clinical Solutions is a company based in Bengaluru (India) founded in 2014. It operates as a B2B. D2L Clinical Solutions operates in a competitive market with competitors including SSI Strategy, Fusion Antibodies, Health Decisions, August Research and Phastar, among others.
- Headquarter Bengaluru, India
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name D2l Clinical Solutions Private Limited
- Date of Incorporation 15 Jul, 2014
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$311.34 K (USD)0as on Mar 31, 2017
-
Net Profit
$33.19 K (USD)0as on Mar 31, 2017
-
EBITDA
$50.39 K (USD)0as on Mar 31, 2017
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of D2L Clinical Solutions
Detailed funding history for D2L Clinical Solutions
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by D2L Clinical Solutions
Investment portfolio details for D2L Clinical Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - D2L Clinical Solutions
Detailed financials for D2L Clinical Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
D2l Clinical Solutions Comparisons
Peer comparison for D2L Clinical Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of D2L Clinical Solutions
D2L Clinical Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SSI Strategy, Fusion Antibodies, Health Decisions, August Research and Phastar, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacovigilance and medical affairs services are offered for drug development.
|
|
| Locked | Locked | Locked |
Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization
|
|
| Locked | Locked | Locked |
CRO focused on clinical trial services for data management, monitoring and biostatistics
|
|
| Locked | Locked | Locked |
Clinical trial services are offered in Central and Eastern Europe.
|
|
| Locked | Locked | Locked |
Statistical consulting and data management for clinical trials are offered.
|
|
| Locked | Locked | Locked |
Regulatory and pharmacovigilance support is provided for product lifecycles.
|
Detailed competitors of D2L Clinical Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on D2l Clinical Solutions
Complete news archive for D2L Clinical Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about D2L Clinical Solutions
D2L Clinical Solutions was founded in 2014.
D2L Clinical Solutions is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Annual revenue of D2L Clinical Solutions is $311.34K as on Mar 31, 2017.
D2L Clinical Solutions, founded in 2014 in Bengaluru, India, focuses on providing healthcare solutions, clinical research, trial management, and project monitoring. Offers comprehensive solutions for clinical trial project monitoring and site management. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
D2L Clinical Solutions's top competitors include SSI Strategy, Fusion Antibodies and ProductLife Group.